Surprisingly, we find that STAG2 knockdown makes BRAF-mutant thyroid cancer cells more sensitive to glutamine deprivation or glutaminase inhibitor via the ERK/AKT/GSK3β/c-Myc feedback axis. Here, GSK3B is linked to thyroid gland carcinoma.